Loading...

LTRN LANTERN PHARMA INC Management Changes 8-K Filing

LNTR

LTRN

LANTERN PHARMA INC

(LTRN)

2025 8-K

Show Summary

Show Summary

Equity Offerings

Financial Statements

Financial Results

Management Changes

Q3 Results Call

Q3 Earnings Announcement

Annual Meeting of Stockholders

By-laws Amendment

Earnings Reports

Earnings Reports

Management Changes

Investment Agreement

Death of Director

Earnings Reports

Annual Meeting of Stockholders

Earnings Reports

Earnings Reports

Salary Increase

External Links:

Lantern Pharma Inc. extended Chief Scientific Officer Kishor G. Bhatia's employment agreement until January 15, 2026, adjusting his weekly hours to 24 and annual salary to $189,600 starting January 2025.

AI Assistant

LANTERN PHARMA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.